Hon ANDREW LITTLE (Minister of Health): It's important that we have a range of medicines to treat those who do get sick with COVID-19. That's why I'm pleased to say that, on Monday, we announced that the national drug funding agency, Pharmac, has secured from Pfizer 60,000 courses of another antiviral medicine, which, like molnupiravir, which we secured in October, can be taken as a tablet. Both medications stop people with mild symptoms from becoming very sick. Alongside vaccinations, our hospital treatments are already reducing the likelihood of people needing ICU care, with the ICU rate in Auckland dropping to 3 percent of hospitalisations, down from 5.7 percent previously. Of course, vaccinations and following the "scan, mask, pass" routine are still the best ways of stopping the spread of COVID-19.